$2.56
0[0.00%]
At close: May 13
$2.56
0[0.00%]
PreMarket: 7:38PM EDT
Bio-Path Hldgs
(NASDAQ:BPTH)Bio-Path Hldgs Stock (NASDAQ:BPTH), Quotes and News Summary
Bio-Path Hldgs Stock (NASDAQ: BPTH) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 71.000 / 1.446M |
| Day Range | - - - |
| 52 Wk Range | 2.350 - 44.800 |
| Market Cap | $4.007M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 38 |
| Short Interest | 1.75% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bio-Path Hldgs (BPTH) stock?
You can purchase shares of Bio-Path Hldgs (NASDAQ: BPTH) through any online brokerage.
Who are Bio-Path Hldgs's (BPTH) competitors?
Other companies in Bio-Path Hldgs’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
What is the target price for Bio-Path Hldgs (BPTH) stock?
The latest price target for Bio-Path Hldgs (NASDAQ: BPTH) was reported by Roth MKM on Thursday, April 18, 2024. The analyst firm set a price target for 40.00 expecting BPTH to rise to within 12 months (a possible 1462.50% upside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Bio-Path Hldgs (BPTH)?
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $2.56 last updated May 13, 2024 at 7:38 PM EDT.
Does Bio-Path Hldgs (BPTH) pay a dividend?
There are no upcoming dividends for Bio-Path Hldgs.
When is Bio-Path Hldgs (NASDAQ:BPTH) reporting earnings?
Bio-Path Hldgs’s Q2 earnings are confirmed for Tuesday, August 13, 2024.
Is Bio-Path Hldgs (BPTH) going to split?
There is no upcoming split for Bio-Path Hldgs.
What sector and industry does Bio-Path Hldgs (BPTH) operate in?
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.